Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 16,626 shares at $14.55 ($242K) on 2021-05-18, disclosed to the SEC on 2021-05-20.
Open-market sale of $242k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.55 | 8,313 | $121K | 50.0% |
| 2 | $14.55 | 8,313 | $121K | 50.0% |
| Total | $14.55 avg | 16,626 | $242K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |